Work

Combination Therapy With Plasmapheresis, IVIG, and Rituximab Provides Benefit in the Management of Early Antibody Mediated Rejection in Lung Transplant in a Pilot Cohort

FWCI: 0.328
Cites:
Cited by: 2
Related to: 10